ZappRx Stock
Prescription & Prior Authorization Platform
Sign up today and learn more about ZappRx Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About ZappRx Stock
ZappRx is a digital health company that is modernizing and simplifying the way specialty drugs are managed. We provide a secure, collaborative online platform that allows patients, physicians, and pharmacists to work together to improve patients’ access to treatment and deliver medicine faster.
Investors
Funding History
| September 2013 | $1.0M |
|---|---|
| January 2014 | $1.0M |
| April 2015 | $14.0M |
| April 2017 | $25.0M |
Management
Founder & CEO
Zoe Barry
Chief Operating Officer
Sandy DiCesare
Press
Business Wire (press release) - Nov, 28 2017
ZappRx Bolsters Company Growth with Strategic Executive Hires, and Advances Mission to Streamline Specialty ...Business Wire (press release) - Nov, 21 2017
Matter Communications Named PR Agency of Record (AOR) for ZappRxLung Disease News - Jul, 25 2017
ZappRx Implements Specialty Medication Prescribing Platform at 2 Pulmonary Medical CentersPR Newswire (press release) - Jul, 20 2017
ZappRx Launches Specialty Drug Prescribing Platform at Arizona Pulmonary Specialists and Harbor-UCLA Medical ...TechCrunch - Apr, 20 2017
ZappRX gets $25 million from Qiming US to expand into the US drug prescription marketEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
